Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick Chappell

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Statistics in Medicine|April 5, 2020
Imbalanced randomization in clinical trialsThevaa Chandereng, Xiaodan Wei, Rick Chappell
Clinical Trials (London, England)|August 22, 2017
University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs? (morning panel discussion)Rick Chappell, Valerie Durkalski, Steven Joffe
International Journal of Radiation Oncology, Biology, Physics|October 7, 2004
New data on the value of alpha/beta--evidence mounts that it is lowRick Chappell, Jack Fowler, Mark Ritter
Controlled Clinical Trials|September 23, 2003
A group sequential, response-adaptive design for randomized clinical trialsTheodore G Karrison, Dezheng Huo, Rick Chappell
Biometrics|July 14, 2005
Semiparametric analysis of survival data with left truncation and dependent right censoringHongyu Jiang, Jason P Fine, Rick Chappell
Clinical Trials (London, England)|July 24, 2014
University of Pennsylvania 6th annual conference on statistical issues in clinical trials: Dynamic treatment regimes (afternoon session)Christy Chuang-Stein, Dean Follman, Rick Chappell
Biostatistics (Oxford, England)|June 17, 2008
Sample size for positive and negative predictive value in diagnostic research using case-control designsDavid M Steinberg, Jason Fine, Rick Chappell
Controlled Clinical Trials|April 12, 2003
Estimating the distribution of nonterminal event time in the presence of mortality or informative dropoutHongyu Jiang, Rick Chappell, Jason P Fine
Clinical Trials (London, England)|November 18, 2015
Sample size under the additive hazards modelLee S McDaniel, Menggang Yu, Rick Chappell
Biometrics|April 21, 2015
Quantile regression with a change-point model for longitudinal data: An application to the study of cognitive changes in preclinical alzheimer's diseaseChenxi Li, N Maritza Dowling, Rick Chappell
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Statistics in Medicine|April 5, 2020
Imbalanced randomization in clinical trialsThevaa Chandereng, Xiaodan Wei, Rick Chappell
Clinical Trials (London, England)|August 22, 2017
University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs? (morning panel discussion)Rick Chappell, Valerie Durkalski, Steven Joffe
International Journal of Radiation Oncology, Biology, Physics|October 7, 2004
New data on the value of alpha/beta--evidence mounts that it is lowRick Chappell, Jack Fowler, Mark Ritter
Controlled Clinical Trials|September 23, 2003
A group sequential, response-adaptive design for randomized clinical trialsTheodore G Karrison, Dezheng Huo, Rick Chappell
Biometrics|July 14, 2005
Semiparametric analysis of survival data with left truncation and dependent right censoringHongyu Jiang, Jason P Fine, Rick Chappell
Clinical Trials (London, England)|July 24, 2014
University of Pennsylvania 6th annual conference on statistical issues in clinical trials: Dynamic treatment regimes (afternoon session)Christy Chuang-Stein, Dean Follman, Rick Chappell
Biostatistics (Oxford, England)|June 17, 2008
Sample size for positive and negative predictive value in diagnostic research using case-control designsDavid M Steinberg, Jason Fine, Rick Chappell
Controlled Clinical Trials|April 12, 2003
Estimating the distribution of nonterminal event time in the presence of mortality or informative dropoutHongyu Jiang, Rick Chappell, Jason P Fine
Clinical Trials (London, England)|November 18, 2015
Sample size under the additive hazards modelLee S McDaniel, Menggang Yu, Rick Chappell
Biometrics|April 21, 2015
Quantile regression with a change-point model for longitudinal data: An application to the study of cognitive changes in preclinical alzheimer's diseaseChenxi Li, N Maritza Dowling, Rick Chappell
Pageof 6